Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation

Clinical Research in Cardiology

Volumn 102, Issue 5, 2013, Pages 345-349

  Said, Samir M ^a   Esperer, Hans D ^a   Hahn, Judit ^a   Bollmann, Andreas ^b   Richter, Sergio ^b   Rauwolf, Thomas ^a   Prondzinsky, Roland ^c   Schmeisser, Alexander ^a   Braun Dullaeus, Ruediger C ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c Carl von Basedow Clinic   (Germany)

Author keywords

Antiplatelet therapy; Bleeding complications; Pacemaker implantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; FEMALE; HEMATOMA; HUMAN; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE;

ADMINISTRATION, ORAL; AGED; ASPIRIN; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CARDIAC PACING, ARTIFICIAL; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HEMATOMA; HEMOGLOBINS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PACEMAKER, ARTIFICIAL; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876503209     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0543-8     Document Type: Article

References (7)

1. Antithrombotic Trialists′ Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86
2. Popma JJ, Berger P, Ohman EM et al (2004) Antithrombotic therapy during percutaneous coronary intervention. Chest 126:567-599
3. Said SM, Hahn J, Schleyer E et al (2007) Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia. Clin Res Cardiol 96:61-69
4. Tompkins C, Cheng A, Dalal D et al (2010) Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 55:2376-2382
5. Kutinsky IB, Jarandilla R, Jewett M, Haines DE (2010) Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 3:312-318
6. Ellenbogen KA, Hellkamp AS, Wilkoff BL et al (2003) Complications arising after implantation of DDD pacemakers: The MOST experience. Am J Cardiol 92:740-741
7. Wiegand UK, LeJeune D, Boguschewski F et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest 126:1177-1186